Clinical Trial Update: Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment [Phase 3]

View source ↗

Summary

Exploratory Phase 3 trial assessing the efficacy and safety of semaglutide for idiopathic intracranial hypertension has not yet recruited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Intracranial Hypertension

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Capital Medical University | Conditions: Idiopathic Intracranial Hypertension | Phase 3 | Status: NOT_YET_RECRUITING